<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11864858</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.155</article-id><article-id pub-id-type="other">O0020</article-id><article-id pub-id-type="pii">S092493382400155X</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>Oral Communication</subject></subj-group></article-categories><title-group><article-title>Psychotherapies for generalized anxiety disorder in adults: systematic review and network meta-analysis of randomized-controlled trials</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Papola</surname><given-names>D.</given-names></name><xref rid="aff0061" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff0062" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cor0016" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Miguel Sanz</surname><given-names>C.</given-names></name><xref rid="aff0063" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Mazzaglia</surname><given-names>M.</given-names></name><xref rid="aff0062" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Franco</surname><given-names>P.</given-names></name><xref rid="aff0064" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Tedeschi</surname><given-names>F.</given-names></name><xref rid="aff0062" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Romero</surname><given-names>S. A.</given-names></name><xref rid="aff0061" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Patel</surname><given-names>A. R.</given-names></name><xref rid="aff0061" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ostuzzi</surname><given-names>G.</given-names></name><xref rid="aff0062" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gastaldon</surname><given-names>C.</given-names></name><xref rid="aff0062" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Karyotaki</surname><given-names>E.</given-names></name><xref rid="aff0063" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Harrer</surname><given-names>M.</given-names></name><xref rid="aff0065" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Purgato</surname><given-names>M.</given-names></name><xref rid="aff0062" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Sijbrandij</surname><given-names>M.</given-names></name><xref rid="aff0063" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Patel</surname><given-names>V.</given-names></name><xref rid="aff0061" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Furukawa</surname><given-names>T. A.</given-names></name><xref rid="aff0066" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Cuijpers</surname><given-names>P.</given-names></name><xref rid="aff0063" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Barbui</surname><given-names>C.</given-names></name><xref rid="aff0062" ref-type="aff">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="aff0061"><sup>1</sup>Global health and Social Medicine, <institution>Harvard Medical School</institution>, <city>Boston</city>, <country>United States</country></aff><aff id="aff0062"><sup>2</sup>Neuroscience, Biomedicine and Movement Sciences, <institution>University of Verona</institution>, <city>Verona</city>, <country>Italy</country></aff><aff id="aff0063"><sup>3</sup>Clinical, Neuro- and Developmental Psychology, Section of Clinical Psychology, Vrije Universiteit, <city>Amsterdam</city>, <country>Netherlands</country></aff><aff id="aff0064"><sup>4</sup>School of Psychology, Pontificia Universidad Cat&#x000f3;lica de Chile, <city>Santiago</city>, <country>Chile</country></aff><aff id="aff0065"><sup>5</sup>Psychology &#x00026; Digital Mental Health Care, Department of Health Sciences, Technical University Munich, <city>Munich</city>, <country>Germany</country></aff><aff id="aff0066"><sup>6</sup>Health Promotion and Human Behavior, <institution>Kyoto University Graduate School of Medicine/School of Public Health</institution>, <city>Kyoto</city>, <country>Japan</country></aff><author-notes><corresp id="cor0016"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="130">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S50</fpage><lpage>S51</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S092493382400155Xa.pdf"/><abstract><sec id="sec0091"><title>Introduction</title><p>Generalized anxiety disorder (GAD) is one of the most common mental disorders in adults. Psychotherapies are among the most recommended treatment choices for GAD, but which should be considered as first-line treatment still needs to be clarified.</p></sec><sec id="sec0092"><title>Objectives</title><p>To examine the most effective and accepted psychotherapy for GAD both in the short and long-term, via a network meta-analysis.</p></sec><sec id="sec0093"><title>Methods</title><p>We searched MEDLINE, Embase, PsycINFO, and the Cochrane Register of Controlled Trials &#x02013; CENTRAL, from database inception to January 1st, 2023, to find randomized controlled trials (RCTs) of psychotherapies for GAD. Eight psychotherapies (behaviour therapy, cognitive-behaviour therapy, cognitive restructuring, psychoeducation, psychodynamic therapy, relaxation therapy, supportive psychotherapy, and third-wave CBTs) were compared with each other and two control conditions (treatment as usual, waiting list). We followed Cochrane standards when extracting data and assessing data quality and used PRISMA guidelines for the reporting. We conducted random-effects model pairwise and network meta-analyses. We assessed risk of bias of individual studies through the second version of the Cochrane&#x02019;s Risk of Bias tool and used the Confidence in Network Meta-Analysis (CINeMA) to rate certainty of evidence for meta-analytical results. Severity of GAD symptoms and acceptability of the psychotherapies were our outcomes of interest.</p></sec><sec id="sec0094"><title>Results</title><p>We analysed data from 66 RCTs. Effect size estimates on data from 5,597 participants suggest third wave cognitive-behavioural therapies (standardized mean differences [SMDs] =-0.78; 95%CI=-1.19 to -0.37; certainty=moderate), cognitive-behavioural therapy (CBT) (SMD=-0.68; 95%CI=-1.05 to -0.32 certainty=moderate), and relaxation therapy (SMD=-0.54; 95%CI=-1.04 to -0.05; certainty=low) reduced generalized anxiety symptoms more than treatment as usual (TAU). Relative risks for all-cause discontinuation signalled no differences compared with TAU for all psychotherapies. When excluding studies at high risk of bias, relaxation therapy lost its superiority over TAU. When considering anxiety severity at three to twelve months after completion of the intervention only CBT remained significantly more efficacious than TAU (SMD=-0.58; 95%CI=-0.93 to -0.23).</p><p>
<bold>Image:</bold>
</p><p><fig position="float" id="fig0188"><graphic xlink:href="S092493382400155X-FIG0188" position="anchor"/></fig>
</p></sec><sec id="sec0095"><title>Conclusions</title><p>Given the evidence for both acute and long-term efficacy, CBT may represent the reasonable first-line psychological treatment for GAD. Third-wave CBT and relaxation therapy have short-term efficacy and may also be offered. Results from this investigation should inform patients, clinicians, and guidelines. This project is funded by the European Union&#x02019;s HORIZON EUROPE research programme under grant agreement No 101061648.</p></sec><sec id="sec0096"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="2"/></counts></article-meta></front></article>